FDA berates Chinese drugmaker tied to global valsartan recall

21st September 2018 Uncategorised 0

FDA inspectors last month spent two weeks inspecting the plant of Chinese API maker Zhejiang Huahai Pharmaceutical after learning its valsartan contained an impurity that is a suspected carcinogen.

More: FDA berates Chinese drugmaker tied to global valsartan recall
Source: fierce